Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-06

Clinical Trial Update: REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating scatter laser guided by UWFA in combination with ranibizumab for macular edema due to branch retinal vein occlusion; trial completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lucentis (ranibizumab)

Snippet

Sponsor: Retina Associates of Florida, P.A. | Conditions: Macular Edema, Branch Retinal Vein Occlusion | Phase 2 | Status: COMPLETED | Results posted: 2014-10-06